US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 844.270
  • -26.090-3.00%
Close Feb 14 16:00 ET
  • 844.000
  • -0.270-0.03%
Post 20:01 ET
801.48BMarket Cap72.10P/E (TTM)

About Eli Lilly and Co Company

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Company Profile

SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com

Company Executives

  • Name
  • Position
  • Salary
  • David A. Ricks
  • Chairman of the Board, President and Chief Executive Officer
  • 26.57M
  • Donald A. Zakrowski
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Diogo Rau
  • Executive Vice President, Chief Information Officer and Chief Digital Officer
  • --
  • Alonzo Weems
  • Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
  • --
  • Lucas Montarce
  • Executive Vice President and Chief Financial Officer
  • --
  • Dr. Daniel M. Skovronsky, M.D.
  • Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
  • 11.85M
  • Jacob S. Van Naarden
  • Executive Vice President and President, Loxo
  • 4.89M
  • Anat Hakim
  • Executive Vice President, General Counsel and Secretary
  • 7.01M
  • Ilya Yuffa
  • Executive Vice President and President, Lilly International
  • --
  • Johna L. Norton
  • Executive Vice President, Global Quality
  • --
  • Eric Dozier
  • Executive Vice President, Human Resources and Diversity
  • --
  • Edgardo Hernandez
  • Executive Vice President and President, Manufacturing Operations
  • --
  • Patrik Jonsson
  • Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
  • --
  • Anne E. White
  • Executive Vice President and President, Lilly Neuroscience
  • --
  • Kimberly H. Johnson
  • Independent Director
  • 316.00K
  • Gabrielle Sulzberger, J.D.,M.B.A.
  • Independent Director
  • 335.50K
  • Juan R. Luciano
  • Lead Independent Director
  • 373.00K
  • Jamere Jackson
  • Independent Director
  • 345.00K
  • Jon R. Moeller
  • Independent Director
  • --
  • Dr. Mary Lynne Hedley,PhD
  • Independent Director
  • 319.00K
  • Dr. William G. Kaelin, Jr
  • Independent Director
  • 349.15K
  • Jon Erik Fyrwald
  • Independent Director
  • 344.88K
  • Ralph Alvarez
  • Independent Director
  • 336.00K
  • Katherine Baicker
  • Independent Director
  • 336.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!